Generalized Lipodystrophy Gld

1

Review clinical trials related to Generalized Lipodystrophy Gld. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease

Location

Anywhere

By Last updated

Status: Available

Expanded Access to REGN4461 for Patients With Diseases Associated With Deficient Leptin Signaling

Provide Expanded Access to REGN4461 for patients with diseases associated with deficient leptin signaling.

Trial details

Biological sex: AllType: Expanded AccessSponsor: Regeneron PharmaceuticalsUpdated: Mar 12, 2026

Eligibility criteria

Not listed